News
Reaching the SDG targets on Health by 2030: ECDC Session at European Health Forum Gastein 2018
Will we reach the United Nations Sustainable Development Goal (SDG) for health by 2030 and the targets set for HIV/AIDS, hepatitis and tuberculosis?
News
Marking European Testing Week: ECDC issues integrated hepatitis and HIV testing Guidance
To mark European Testing Week from 23 to 30 November 2018, ECDC publishes its new Guidance on integrated viral hepatitis and HIV testing.
External Link
HIV in Europe and Central Asia: progress in 2018 towards meeting the UNAIDS 90-90-90 targets
In 2014, the Joint United National Programme on HIV/AIDS (UNAIDS) established the global 90–90–90 targets. The aim was for 90% of all people living with HIV (PLHIV) to be diagnosed, 90% of those diagnosed to receive antiretroviral treatment (ART) and 90% of those receiving treatment to achieve viral suppression, by 2020. This article describes progress towards the UNAIDS 90–90–90 targets across Europe and Central Asia and discuss whether current performance is sufficient to eliminate HIV transmission.
News
Ending the HIV epidemic: where does Europe stand?
From diagnosis of HIV to successful viral suppression: in a rapid communication published in Eurosurveillance, ECDC and co-authors from Public Health England and The National AIDS Trust summarise the progress towards HIV elimination in 52 countries in Europe and Central Asia. The main issues: diagnosing those who are unaware of their HIV infection and treating them.
News
It is always time to test: Spring European Testing Week
In order to maximise the benefits of treatment for HIV or viral hepatitis, it is critical to test and diagnose people as soon as possible in the course of the infection. ECDC supports this objective of European Testing Week.
News
Around half a million men who have sex with men in the EU need PrEP but cannot access it
This estimate on the “PrEP gap” in Europe was published in a paper in Eurosurveillance stating that 500 000 men who have sex with men in the European Union currently cannot access HIV pre-exposure prophylaxis (PrEP), despite being very likely to use it.